<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01241149</url>
  </required_header>
  <id_info>
    <org_study_id>CIP# 10.0090</org_study_id>
    <nct_id>NCT01241149</nct_id>
  </id_info>
  <brief_title>Prospective Evaluation of Symptom Resolution in Acid Versus Non-acid Reflux Disease Following Anti-reflux Surgery</brief_title>
  <official_title>Prospective Evaluation of Symptom Resolution in Acid Versus Non-acid Reflux Disease Following Anti-reflux Surgery.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>United States Naval Medical Center, Portsmouth</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>United States Naval Medical Center, Portsmouth</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Gastroesophageal reflux disease (GERD) is a common ailment affecting a significant portion of&#xD;
      the US population. With the advent and increased use of esophageal impedance monitoring, both&#xD;
      acid and nonacid reflux disease can be better diagnosed and treated. Patients with severe&#xD;
      symptoms or symptoms refractory to medical management may be offered anti-reflux surgery for&#xD;
      optimal treatment. Though there are a handful of studies evaluating the efficacy of&#xD;
      anti-reflux surgery on those patients with acid or non-acid related reflux disease, the&#xD;
      comparison between acid and non-acid reflux disease following surgery is lacking. We propose&#xD;
      a prospective study comparing clinical outcomes from those patients with acid versus non-acid&#xD;
      reflux disease following anti-reflux surgery with the use of validated and disease specific&#xD;
      quality of life surveys.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>November 2010</start_date>
  <primary_completion_date type="Anticipated">November 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Effectiveness of anti-reflux surgery</measure>
    <time_frame>1 year</time_frame>
    <description>To prospectively evaluate the effectiveness of anti-reflux surgery, as measured by symptom reduction, in the treatment of nonacid reflux disease compared prospectively with acid reflux disease.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">32</enrollment>
  <condition>Non-acid Reflux Disease</condition>
  <arm_group>
    <arm_group_label>Normal pH, abnormal Impedance</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>After 24hr pH-metry and impedance, those patients with normal pH (i.e. DeMeester score &lt;14.7) but with abnormal impedance scores will be offered anti-reflux surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Abnormal pH</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>After 24hr pH-metry and impedance, those with abnormal pH scores (i.e. DeMeester score &gt;14.7)will be offered anti-reflux surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>anti-reflux surgery</intervention_name>
    <description>Anti-reflux surgery (Laparoscopic Nissen Fundoplication)</description>
    <arm_group_label>Abnormal pH</arm_group_label>
    <arm_group_label>Normal pH, abnormal Impedance</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients who are offered anti-reflux surgical treatment with elevated DeMeester scores&#xD;
             or with low (less than 14.7) DeMeester scores, but with positive impedance scores&#xD;
             (positive symptom index associated with reflux episodes).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  â€¢ Previous major upper gastrointestinal surgery (includes esophagus, stomach, and&#xD;
             duodenum) - previous cholecystectomy (gallbladder removal) is not considered a major&#xD;
             upper GI surgery&#xD;
&#xD;
               -  Presence of paraesophageal hernia (type II - type IV)&#xD;
&#xD;
               -  Presence of large hiatal hernia &gt;5cm&#xD;
&#xD;
               -  Presence of peptic strictures&#xD;
&#xD;
               -  History of severe esophageal motility disorders such as:&#xD;
&#xD;
                    -  achalasia&#xD;
&#xD;
                    -  diffuse esophageal spasms&#xD;
&#xD;
                    -  scleroderma&#xD;
&#xD;
                    -  poorly-controlled diabetes mellitus&#xD;
&#xD;
                    -  autonomic or peripheral neuropathy&#xD;
&#xD;
                    -  myopathy&#xD;
&#xD;
               -  Pregnancy (As a standard operating procedure, women of child-bearing age will&#xD;
                  undergo a urine pregnancy test the morning of surgery because anti-reflux surgery&#xD;
                  is considered an elective case, where pregnancy is a relative contraindication.)&#xD;
&#xD;
               -  BMI greater than 40&#xD;
&#xD;
               -  Undergoes Collis gastroplasty during surgery&#xD;
&#xD;
               -  Conversion to an open procedure&#xD;
&#xD;
               -  Age less than 18 years old&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>17 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ellie Mentler, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>United States Naval Medical Center, Portsmouth</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ellie Mentler, MD</last_name>
    <phone>757-953-2454</phone>
    <email>ellie.mentler@med.navy.mil</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Charles Morgan, PhD</last_name>
    <phone>757-953-5939</phone>
    <email>charles.morgan@med.navy.mil</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Naval Medical Center Portsmouth</name>
      <address>
        <city>Portsmouth</city>
        <state>Virginia</state>
        <zip>23708</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ellie Mentler, MD</last_name>
      <phone>757-953-2454</phone>
      <email>ellie.mentler@med.navy.mil</email>
    </contact>
    <contact_backup>
      <last_name>Charles Morgan, PhD</last_name>
      <phone>757-953-5939</phone>
      <email>charles.morgan@med.navy.mil</email>
    </contact_backup>
    <investigator>
      <last_name>Ellie Mentler, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Cade Cinnamond, DO</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michael Barker, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>John Smith, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Andrew Gentry, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Delores Rhodes, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2010</verification_date>
  <study_first_submitted>November 15, 2010</study_first_submitted>
  <study_first_submitted_qc>November 15, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 16, 2010</study_first_posted>
  <last_update_submitted>November 15, 2010</last_update_submitted>
  <last_update_submitted_qc>November 15, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 16, 2010</last_update_posted>
  <responsible_party>
    <name_title>LT Ellie Mentler</name_title>
    <organization>Naval Medical Center Portsmouth</organization>
  </responsible_party>
  <keyword>Nissen fundoplication</keyword>
  <keyword>non-acid reflux disease</keyword>
  <keyword>anti-reflux surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gastroesophageal Reflux</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

